411 related articles for article (PubMed ID: 25445234)
1. Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.
Christenson ES; James T; Agrawal V; Park BH
Clin Biochem; 2015 Mar; 48(4-5):223-35. PubMed ID: 25445234
[TBL] [Abstract][Full Text] [Related]
2. The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study.
Lenihan DJ; Stevens PL; Massey M; Plana JC; Araujo DM; Fanale MA; Fayad LE; Fisch MJ; Yeh ET
J Card Fail; 2016 Jun; 22(6):433-8. PubMed ID: 27079675
[TBL] [Abstract][Full Text] [Related]
3. Cardiotoxicity due to Chemotherapy: the Role of Biomarkers.
Stevens PL; Lenihan DJ
Curr Cardiol Rep; 2015 Jul; 17(7):603. PubMed ID: 26026994
[TBL] [Abstract][Full Text] [Related]
4. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.
Blaes AH; Rehman A; Vock DM; Luo X; Menge M; Yee D; Missov E; Duprez D
Vasc Health Risk Manag; 2015; 11():591-4. PubMed ID: 26648730
[TBL] [Abstract][Full Text] [Related]
5. Utilizing cardiac biomarkers to detect and prevent chemotherapy-induced cardiomyopathy.
Singh D; Thakur A; Tang WH
Curr Heart Fail Rep; 2015 Jun; 12(3):255-62. PubMed ID: 25869733
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use.
Dolci A; Dominici R; Cardinale D; Sandri MT; Panteghini M
Am J Clin Pathol; 2008 Nov; 130(5):688-95. PubMed ID: 18854260
[TBL] [Abstract][Full Text] [Related]
7. [The role of biochemical markers with special regard to troponin, CK-MB, NT-proBNP as early biomarkers of cardiotoxicity among women after chemotherapy due to breast cancer].
Stachowiak P; Milchert-Leszczyńska M; Falco M; Polakowska M; Wojtarowicz A; Kaliszczak R; Safranow K; Kornacewicz-Jach Z
Przegl Lek; 2016; 73(6):359-63. PubMed ID: 29668198
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers as Predictors of Cardiac Toxicity From Targeted Cancer Therapies.
Witteles RM
J Card Fail; 2016 Jun; 22(6):459-64. PubMed ID: 27038641
[TBL] [Abstract][Full Text] [Related]
9. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
Akhter N; Murtagh G; Yancy C
Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
[TBL] [Abstract][Full Text] [Related]
10. Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value.
Adamcova M; Lencova-Popelova O; Jirkovsky E; Mazurova Y; Palicka V; Simko F; Gersl V; Sterba M
Int J Cardiol; 2015 Dec; 201():358-67. PubMed ID: 26310978
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity and cancer therapy: treatment-related cardiac morbidity in patients presenting with symptoms suggestive of heart or lung disease.
Wieshammer S; Dreyhaupt J; Müller D; Momm F; Jakob A; Freund U
Oncology; 2013; 85(3):137-44. PubMed ID: 23948797
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxic effects and myocardial injury: the search for a more precise definition of drug cardiotoxicity.
Cardinale DM; Zaninotto M; Cipolla CM; Passino C; Plebani M; Clerico A
Clin Chem Lab Med; 2020 Aug; 59(1):51-57. PubMed ID: 32845860
[TBL] [Abstract][Full Text] [Related]
13. Role of biomarkers in chemotherapy-induced cardiotoxicity.
Cardinale D; Sandri MT
Prog Cardiovasc Dis; 2010; 53(2):121-9. PubMed ID: 20728699
[TBL] [Abstract][Full Text] [Related]
14. Cardiac troponin T and NT-proBNP as biomarkers of early myocardial damage in amitriptyline-induced cardiovascular toxicity in rats.
Sorodoc V; Sorodoc L; Ungureanu D; Sava A; Jaba IM
Int J Toxicol; 2013; 32(5):351-7. PubMed ID: 24055824
[TBL] [Abstract][Full Text] [Related]
15. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.
Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L
Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647
[TBL] [Abstract][Full Text] [Related]
16. Paving the Route to Plasma miR-208a-3p as an Acute Cardiac Injury Biomarker: Preclinical Rat Data Supports Its Use in Drug Safety Assessment.
Glineur SF; De Ron P; Hanon E; Valentin JP; Dremier S; Nogueira da Costa A
Toxicol Sci; 2016 Jan; 149(1):89-97. PubMed ID: 26454886
[TBL] [Abstract][Full Text] [Related]
17. [Biochemical markers for predicting chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use].
Dolci A; Dominici R; Cardinale D; Sandri MT; Panteghini M
G Ital Cardiol (Rome); 2006 Sep; 7(9):604-11. PubMed ID: 17128782
[TBL] [Abstract][Full Text] [Related]
18. Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.
Kang Y; Xu X; Cheng L; Li L; Sun M; Chen H; Pan C; Shu X
Eur J Heart Fail; 2014 Mar; 16(3):300-8. PubMed ID: 24464946
[TBL] [Abstract][Full Text] [Related]
19. High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study.
Onitilo AA; Engel JM; Stankowski RV; Liang H; Berg RL; Doi SA
Breast Cancer Res Treat; 2012 Jul; 134(1):291-8. PubMed ID: 22476854
[TBL] [Abstract][Full Text] [Related]
20. The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature.
Mavinkurve-Groothuis AM; Kapusta L; Nir A; Groot-Loonen J
Pediatr Hematol Oncol; 2008 Sep; 25(7):655-64. PubMed ID: 18850478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]